Transplant Genomics: Peter Meintjes
Eurofins-Transplant Genomics has appointed Peter Meintjes as chief commercial officer to lead the commercialization of the company's TruGraf blood test for kidney transplant surveillance. Meintjes joins TGI after six years at Omixon, where most recently served as CEO after having also held the roles of chief commercial officer and director of US operations. Meintjes also previously worked as VP of business development for Biomatters.
Cleveland Clinic: Timothy Chan
Timothy Chan has been appointed director of the Center for Immunotherapy and Precision Immuno-oncology at Cleveland Clinic. Chan joins the clinic from Memorial Sloan Kettering Cancer Center and Weill Cornell School of Medicine, where he chaired the immunogenomics and precision oncology platform and was a tenured professor. He also was chair of the translational oncology division. Chan also joins the leadership of the National Center for Regenerative Medicine of Case Western Reserve University; and is on staff at the Genomic Medicine Institute of the Lerner Research Institute and the Department of Radiation Oncology of the Taussig Cancer Institute. He holds an MD and PhD in genetics from Johns Hopkins University, where he also completed a residency in radiation oncology and postdoc in tumor biology.
Grail: Satnam Alag
Grail has appointed Satnam Alag as senior VP of software engineering. Prior to Grail, Alag most recently served as VP of software engineering, product development at Illumina. Before Illumina, Alag was chief technology officer at NextBio, which was acquired by Illumina in 2013. Alag has also held other senior software architecture positions, including chief software architect at Deem.
For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.